Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression

References

• Duruisseaux M, Esteller M. Lung cancer epigenetics: from knowledge to applications. Semin Cancer Biol. 2018;51:116–128.
   PubMed Web of Science ®Google Scholar
• Tsim S, O'Dowd CA, Milroy R, et al. Staging of non-small cell lung cancer (nsclc): a review. Respir Med. 2010;104:1767–1774.
   PubMed Web of Science ®Google Scholar
• Watanabe SI, Nakagawa K, Suzuki K. Neoadjuvant and adjuvant therapy for stage III non-small cell lung cancer. Jpn J Clin Oncol. 2017;47:1112–1118.
   PubMed Web of Science ®Google Scholar
• PDQ Adult Treatment Editorial Board. Non-small cell lung cancer treatment (PDQ®): patient version. Bethesda (MD): National Cancer Institute; 2002; (PDQ cancer information summaries).
   Google Scholar
• Kutkowska J, Porębska I, Rapak A. Non-small cell lung cancer - mutations, targeted and combination therapy. Postepy Hig Med Dosw. 2017;71:431–445.
   Web of Science ®Google Scholar
• Hirsch FR, Suda K, Wiens J, et al. New and emerging targeted treatments in advanced non-small-cell lung cancer. Lancet. 2016;388:1012–1024.
   PubMed Web of Science ®Google Scholar
• Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: identification, biogenesis and function. Biochim Biophys Acta. 2016;1859:163–168.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang J, Khanabdali R, et al. Circular RNAs: isolation, characterization and their potential role in diseases. RNA Biol. 2017;14:1715–1721.
   PubMed Web of Science ®Google Scholar
• Haque S, Harries LW. Circular RNAs (circRNAs) in health and disease. Genes. 2017;8:1–17.
   Web of Science ®Google Scholar
• Greene J, Baird AM, Brady L. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:1–11.
   PubMed Web of Science ®Google Scholar
• Patop IL, Kadener S. CircRNAs in cancer. Curr Opin Genet Dev. 2018;48:121–127.
   PubMed Web of Science ®Google Scholar
• Liu T, Liu S, Xu Y, et al. Circular RNA-ZFR inhibited cell proliferation and promoted apoptosis in gastric cancer by sponging mir-130a/mir-107 and modulating PTEN. Cancer Res Treat. 2018;50:1396–1417.
   PubMed Web of Science ®Google Scholar
• Tan A, Li Q, Chen L. CircZFR promotes hepatocellular carcinoma progression through regulating mir-3619-5p/ctnnb1 axis and activating Wnt/β-catenin pathway. Arch Biochem Biophys. 2019;661:196–202.
   PubMed Web of Science ®Google Scholar
• Wei H, Pan L, Tao D, et al. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging mir-1261 and facilitating c8orf4 expression. Biochem Biophys Res Commun. 2018;503:56–61.
   PubMed Web of Science ®Google Scholar
• Zhu LP, He YJ, Hou JC, et al. The role of circRNAs in cancers. Biosci Rep. 2017;37:1–21.
   Web of Science ®Google Scholar
• Qian L, Yu S, Chen Z, et al. The emerging role of circRNAs and their clinical significance in human cancers. Biochim Biophys Acta Rev Cancer. 2018;1870:247–260.
   PubMed Web of Science ®Google Scholar
• Yao JT, Zhao SH, Liu QP, et al. Over-expression of circRNA_100876 in non-small cell lung cancer and its prognostic value. Pathol Res Pract. 2017;213:453–456.
   PubMed Web of Science ®Google Scholar
• Liu T, Song Z, Gai Y. Circular rna circ_0001649 acts as a prognostic biomarker and inhibits nsclc progression via sponging mir-331-3p and mir-338-5p. Biochem Biophys Res Commun. 2018;503:1503–1509.
   PubMed Web of Science ®Google Scholar
• Liu P, Ye F, Xie X, et al. Mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting ampk. Oncotarget. 2016;7:35188–35198.
   PubMedGoogle Scholar
• Li L, Shao MY, Zou SC, et al. Mir-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44. J Neurooncol. 2019;141:19–30.
   PubMed Web of Science ®Google Scholar
• Moshiri F, Salvi A, Gramantieri L, et al. Circulating mir-106b-3p, mir-101-3p and mir-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 2018;9:15350–15364.
   PubMedGoogle Scholar
• Lu HM, Yi WW, Ma YS, et al. Prognostic implications of decreased microRNA-101-3p expression in patients with non-small cell lung cancer. Oncol Lett. 2018;16:7048–7056.
   PubMed Web of Science ®Google Scholar
• Zhang X, He X, Liu Y, et al. Mir-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking pi3k/akt signal pathway by targeting malat-1. Biomed Pharmacother. 2017;93:1065–1073.
   PubMed Web of Science ®Google Scholar
• Mi J, Zou Y, Lin X, et al. Dysregulation of the mir-194-cul4b negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma. Mol Oncol. 2017;11:305–319.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen Z. Knockdown of cul4b suppresses the proliferation and invasion in non-small cell lung cancer cells. Oncol Res. 2016;24:271–277.
   PubMed Web of Science ®Google Scholar